Once again, the Pharmaceuticals sector exhibits an upward trend, with RMDA, ISPH, and PHAR spearheading the industry. Ibn-Sina Pharma (ISPH) stands out with an impressive performance, trading at EGP 3.92 per share, representing a significant increase of +14.10%. This surge has propelled ISPH to achieve a new 52-week high price and a remarkable year-to-date (YTD) performance of +27%. Following closely behind is 10th Of Ramadan For Medicine Industries (RMDA), boasting a YTD performance of +52% and trading at EGP 2.54 per share, showing a notable increase of +9.48%. These developments highlight the pharmaceutical sector's strong growth and investor confidence in the market.
Prices as of:13/02/2024 11:47 CLT
Disclaimer and Terms of Use
The data provided on any page at www.egvest.com aren't for any investment decision or taking any action of buy or sell of any asset or investments of any type; the information on this page has been obtained from sources that EGEVST believed to be reliable, we have not independently verified such information, and it may not be accurate or complete.
EGVEST.com published a delayed feed for the Egyptian stock exchange executed stocks and its leading indices through a previous contract with EGID "Egypt for Information Dissemination" the delayed feed is referred to below as "information."
The "information" displayed and published by EGVEST.com could lead to financial losses. It should be used on a personal and only personal responsibility. The "information" contains simplified mathematical calculations that clarify, simplify, and classify the "information" without using any financial valuation methods and don't represent any recommendation to buy, sell or hold financial assets.
The Data source is the Central Bank of Egypt website and on this system for display only without any analysis or recommendations
Comments